The global cold disposable biopsy forceps market is expected to achieve a valuation of USD 634.6 million in 2023, with continued growth anticipated over the next decade. The market is forecast to expand at a CAGR of 8.2%, reaching an estimated value of USD 1.4 billion by 2033, according to a recent study by Future Market Insights (FMI).
One of the key drivers of market growth is the increasing demand for minimally invasive procedures, which have gained significant traction in the medical field due to their reduced recovery times, lower risk of infection, and improved patient outcomes. Cold disposable biopsy forceps, which are widely used for tissue sampling during endoscopic procedures, play a critical role in these minimally invasive diagnostic procedures. The demand for these devices is being further propelled by advancements in medical technologies and growing awareness of early disease detection.
In 2023, the oval cups segment is leading the market, accounting for approximately 46.0% of the total market share. These biopsy forceps are particularly popular due to their precision in obtaining tissue samples and their suitability for use in a wide range of diagnostic applications. The versatility and effectiveness of oval cups have made them a preferred choice for healthcare professionals in various clinical settings, including gastroenterology and pulmonology.
The market’s growth is also supported by the rising prevalence of cancer and other chronic diseases, which require frequent biopsies for accurate diagnosis and treatment planning. Additionally, the growing healthcare infrastructure in emerging markets is expected to further fuel demand for these devices. However, the market faces challenges, such as the high cost of advanced biopsy devices and the need for skilled healthcare professionals to operate them. Despite these challenges, the cold disposable biopsy forceps market is on track for sustained growth.
Key Takeaways:
- Market Growth: The cold disposable biopsy forceps market is projected to grow from USD 634.6 million in 2023 to USD 1.4 billion by 2033, at a CAGR of 8.2%.
- Leading Product Segment: Oval cups are the leading product segment, accounting for about 46.0% of the market share in 2023.
- Demand Drivers: Increasing demand for minimally invasive procedures, advancements in medical technology, and the rising incidence of chronic diseases are driving market growth.
- Challenges: High device costs and the need for skilled professionals may impact growth, though the overall market outlook remains positive.
Competitive Landscape
Key players are focusing on novel and innovative approaches for the development of cold disposable biopsy forceps driven by emerging cases of infectious diseases and the lack of advanced methods for efficient disease detection.
The strategy of sales footprint expansion, new product launches, and approvals, by key manufacturers, is further strengthening their market presence.
For instance,
- In June 2021, STERIS plc successfully completed the earlier announced acquisition of Cantel Medical, a leading provider of services and products for infection control to endoscopy, dialysis, dentistry, and life sciences clients.
- Olympus Corporation decided to purchase Quest Photonic Devices B.V. in January 2021 in order to expand its surgical endoscopic capabilities.
Similarly, recent developments related to companies manufacturing cold disposable biopsy forceps have been tracked by the team at Future Market Insight, which is available in the full report.
Get the Comprehensive Full Report Now
Key Market Segments Covered in Cold Disposable Biopsy Forceps Industry Research
By Product:
- Oval Cup
- Oval Cup with Needle
- Alligator Jaw
- Alligator Jaw with Needle
By Diameter:
- 1.2mm
- 1.8mm
- 2.0mm
- 2.4mm
- 2.8mm
- 3.7mm
- 4.0mm
By Length:
- 1150mm
- 1550mm
- 2300mm
By Application:
- Enteroscopy
- Upper GI Endoscopy
- Lower GI Endoscopy
- Bronchoscopy
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
- Diagnostic Laboratories
- Cancer Research Institutes
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
